Results
•
Prognosis of
newly-
diagnosed high-
risk M0 disease
Allocated to control
arm
N=1858
Allocated to research
arms
N=3,715
Randomised by 01-May-
2014
N=5,573
•
Cohort
selection:
71
Non-
metastatic
N=788
Metastati
c
N=1090
Diagnosed within
6m
pre-
randomisation
N=721
Diagnosed more
than 6m
pre-randomisation
N=67